High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.

We conducted a phase II multicenter trial to estimate the response and survival of patients with newly diagnosed multiple myeloma to high dose melphalan therapy followed by autologous peripheral blood stem cell transplantation. Eligible patients who had undergone induction with vincristine, adriamyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, Soo-Mee, Cho, Eun Kyung, Suh, Cheolwon, Yoon, Sung-Soo, Seong, Chu Myung, Cho, Kyung Sam, Kang, Yoon Goo, Park, Seonyang, Ahn, Myung-Ju, Park, Young Suk, Oh, Doyeun, Kim, Hugh C., Jung, Chul Won, Kim, Samyong, Lee, Jae Hoon
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055099/
https://www.ncbi.nlm.nih.gov/pubmed/14555819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055099/
https://www.ncbi.nlm.nih.gov/pubmed/14555819

Ejemplares similares